Arineta Ltd. is a medical technology company specializing in the development and production of innovative cardiac Computed Tomography (CT) scanners. Their flagship product, the CardioGraphe™, is designed to provide high-quality, fast, and low-dose cardiac imaging, making advanced cardiac diagnostics more accessible and efficient for clinicians and patients. Arineta focuses on revolutionizing cardiovascular care by offering dedicated solutions that address the specific needs of cardiology.
The headquarters serves as the central hub for research and development, global operations, corporate leadership, and strategic planning.
Located in a modern industrial park known for fostering innovation, the facility likely includes advanced R&D labs and collaborative workspaces.
The work culture at Arineta's HQ is expected to be innovative, fast-paced, and collaborative, driven by a mission to improve cardiovascular healthcare through cutting-edge technology. Emphasis is likely placed on engineering excellence and clinical impact.
The Caesarea headquarters is significant as it anchors Arineta's R&D efforts in Israel's thriving MedTech ecosystem, allowing access to talent and technological advancements.
Arineta supports its global operations primarily from its headquarters in Israel, focusing on R&D, manufacturing oversight, and strategic partnerships. Their market reach extends to North America, Europe, and Asia through direct sales efforts, distributors, and strategic alliances to ensure installation, service, and clinical support for the CardioGraphe™ system worldwide.
16 Shacham Street, North Industrial Park
Caesarea
N/A (Caesarea is a locality)
Israel
Address: While Arineta may not have direct large-scale offices, they have a significant presence and partnerships in the US, such as with Shared Imaging for mobile CardioGraphe services. Specific office addresses for these partners would vary.
To expand market penetration, provide localized customer support and training, and engage with key opinion leaders and regulatory bodies in the US.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Arineta' leadership includes:
Arineta has been backed by several prominent investors over the years, including:
No major high-profile executive hires or exits publicly announced for Arineta Ltd. in the last 12 months. The company maintains a stable leadership team focused on growth and product development. Any changes are typically part of strategic team strengthening.
Discover the tools Arineta uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Arineta Ltd. likely utilizes standard corporate email formats. The most common patterns for tech companies include first name initial followed by last name, or first name separated by a dot from the last name.
[first_initial][last]@arineta.com
Format
jdoe@arineta.com
Example
90%
Success rate
PR Newswire • November 14, 2023
Arineta announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation CardioGraphe™ system, featuring advanced AI-based image reconstruction and enhanced cardiac imaging capabilities....more
Business Wire • July 11, 2023
Arineta Ltd. announced a distribution agreement with Vector Medical for the CardioGraphe™ dedicated cardiovascular CT system, aiming to expand its footprint in the US market....more
GlobeNewswire • September 7, 2022
Arineta completed a $27 million financing round led by existing investors TriVentures, Galen Partners, and SCP Vitalife, with new participation from Israel Biotech Fund (IBF), to accelerate commercialization and further develop its cardiac CT technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Arineta, are just a search away.